Luoxin Health Technology Development (Beijing) Co., Ltd. signed the capital increase and share transfer agreement that it will raise CNY 5.7 million in an equity round of funding on October 13, 2023. The transaction will include participation from returning investor Luoxin Pharmaceuticals Group Stock Co., Ltd. The transaction has been approved by the 6th session of the company?s 5th directorate and the 5th session of the company?s 5th supervisory board. Luoxin Pharmaceuticals Group Stock Co., Ltd. stake will increase from 51% to 71.16%.